Targeting LRBA triggers CTLA4 degradation and antitumor immunity for cancer immunotherapy
Ontology highlight
ABSTRACT: Targeting LRBA triggers CTLA4 degradation and antitumor immunity for cancer immunotherapy
PROVIDER: PRJNA1266105 | ENA |
REPOSITORIES: ENA
ACCESS DATA